68Ga-PSMA-PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer

Clinical Genitourinary Cancer

Volumn 13, Issue 6, 2015, Pages e415-e417

  Schiavina, Riccardo ^a   Ceci, Francesco ^a   Romagnoli, Daniele ^a   Uprimny, Christian ^b   Brunocilla, Eugenio ^a   Borghesi, Marco ^a   Castellucci, Paolo ^a   Graziani, Tiziano ^a   Fanti, Stefano ^a   Virgolini, Irene ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

68Ga PSMA PET CT; Biochemical relapse; Hormone sensitive; Prostate cancer; PSMA; S LND; Salvage lymph node dissection

Indexed keywords

ANTIANDROGEN; CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN LIGAND GA 68; TRACER; UNCLASSIFIED DRUG; GALLIUM;

ADULT; ARTICLE; BIOCHEMICAL RECURRENCE; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FALSE NEGATIVE RESULT; FOLLOW UP; GLEASON SCORE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; PREOPERATIVE EVALUATION; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; SALVAGE THERAPY; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; METABOLISM; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROSTATIC NEOPLASMS; RETROPERITONEAL NEOPLASMS; SCINTISCANNING; SECONDARY;

GALLIUM RADIOISOTOPES; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROPERITONEAL NEOPLASMS; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84947775132     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2015.06.004     Document Type: Article

References (16)

1. C.R. Pound, A.W. Partin, M.A. Eisenberger, and et al. Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
2. M. Farsad, R. Schiavina, A. Franceschelli, and et al. Positron-emission tomography in imaging and staging prostate cancer Cancer Biomark 4 2008 277 284
3. R. Schiavina, and G. Martorana The promise of choline-PET/CT in the detection of recurrent prostate cancer: what are the limits of our investigation? Eur Urol 63 2012 797 799
4. 11C-choline PET/CT scan before salvage radiation therapy? J Nucl Med 55 2014 1424 1429
5. F. Ceci, K. Herrmann, P. Castellucci, and et al. Impact of (11)C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial Eur J Nucl Med Mol Imaging 41 2014 2222 2231
6. 11C-choline positron emission tomography/computed tomography Eur Urol 60 2011 935 943
7. A. Afshar-Oromieh, C.M. Zechmann, A. Malcher, and et al. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer Eur J Nucl Med Mol Imaging 41 2014 11 20
8. 68Ga-PSMA-ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy J Nucl Med 56 2015 668 674
9. 68Ga-PSMA PET/CT to restage recurrent prostate cancer: which factors are associated with PET/CT detection rate? Eur J Nucl Med Mol Imaging 42 2015 1284 1294
10. 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer Eur J Nucl Med Mol Imaging 42 2015 197 209
11. 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results Eur J Nucl Med Mol Imaging 40 suppl 1 2013 S11 S17
12. 11C-choline PET/CT: new imaging techniques may expand pioneering approaches Urol Int 92 2014 242 245
13. 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients Clin Genitourin Cancer 12 2014 106 110
14. G. Martorana, R. Schiavina, and A. Franceschelli Should we perform imaging-guided lyph node dissection in patients with lymphatic recurrence of prostate cancer after radical prostatectomy? Eur Urol 55 2009 1302 1304
15. N. Suardi, G. Gandaglia, A. Gallina, and et al. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years Eur Urol 67 2015 299 309
16. C.A. Jilg, H.C. Rischke, S.N. Reske, and et al. Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer J Urol 188 2012 2190 2197